Achillion Pharmaceuticals, Inc. (ACHN) Raised at Piper Jaffray, Wells Fargo

Shares of Achillion Pharmaceuticals, Inc. (ACHN) are up almost 8% to $7.93 in pre-market trading Monday. The spike may be attributed to an upgrade to ‘Overweight’ from ‘Neutral’ and a $10.00 from $5.00 price target at Piper Jaffray, which represents expected upside of 42.85% to the stock’s previous closing price of $7.00. From a sentiment […] View the full post at: Achillion Pharmaceuticals, Inc. (ACHN) Raised at Piper Jaffray, Wells Fargo Related posts: Top Pre-Market Stock Upgrades/Downgrades April 21, 2010 Top Pre-Market Stock Upgrades/Downgrades May 3, 2010 Pre-Market Earnings (May 3)